Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Moleculin Biotech Inc | 3 | 27 | 1 | 2 | €0.41 | €18.42 | 4393.659% |
| Evoke Pharma Inc. | 0 | 22 | 0 | 1 | €0.40 | - | - |
| InVivo Therapeutics Holdings | 1 | 18 | 0 | 1 | €0.32 | €1.60 | 403.145% |
| Bellicum Pharmaceuticals Inc. | 0 | 14 | 0 | 1 | €0.064 | - | - |
| T2 Biosystems Inc. | 0 | 13 | 0 | 0 | €0.16 | - | - |
| Trevena Inc. | 1 | 13 | 1 | 3 | €0.33 | €8.37 | 2474.277% |
| BioLase Inc. | 0 | 7 | 0 | 1 | €0.067 | - | - |
| Organovo Holdings Inc. | 0 | 5 | 0 | 1 | €0.94 | €3.00 | 219.149% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.38 | €7.00 | 194.118% |
| Waters Corp. | 0 | 3 | 0 | 0 | €290.80 | €253.83 | -12.715% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.15 | €7.00 | 13.821% |
| Fibrogen Inc. | 2 | 4 | 1 | 1 | €0.95 | €0.000 | -100.000% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 2 | €0.49 | €2.79 | 475.113% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 2 | €0.87 | €6.49 | 642.388% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €2.83 | - | - |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 1 | €3.21 | - | - |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.26 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €3.00 | - | - |
| Agenus Inc. | 2 | 3 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 1 | €0.65 | €3.00 | 363.106% |
| NanoVibronix Inc. | 0 | 1 | 0 | 0 | €0.69 | - | - |
| Neogen Corp. | 1 | 1 | 0 | 0 | €11.30 | €20.08 | 77.733% |
| Vaxart Inc. | 1 | 1 | 1 | 1 | €0.61 | - | - |
| Accelerate Diagnostics Inc. | 1 | 1 | 1 | 0 | €0.88 | - | - |
| Omnicell Inc. | 2 | 2 | 0 | 0 | €25.00 | €51.63 | 106.532% |